News
That's certainly how I felt when I came across the Lyma Laser, a spendy, handheld gadget that claims to have 100 times the ...
The “it goes to 11” of marketing copy. This phrase always looks convincing— it's usually written in all caps at the top of ...
In its yearly survey of international clinicians and patients, Philips illustrated significant gaps in people’s trust when it ...
Advancing commercial readiness efforts with a planned Q1 2026 launch of Anaphylm, subject to FDA approval "In the first quarter of 2025, we achieved a major milestone for Aquestive with the submission ...
Submitted NDA for Anaphylm (epinephrine), the first and only oral sublingual film for patients with severe allergic reactions Advancing commercial readiness efforts with a planned Q1 2026 launch of An ...
Apple’s new brain-to-computer protocol in Switch Control enables iOS, iPadOS, and visionOS devices to support hands-free, thought-based interaction.
More relevantly to the masses is “Augustinus Bader” and “sale,” but it’s happening—all Augustinus Bader products are 20 ...
The lawmakers are racing for a July 4 deadline to have the whole package sent to Trump’s desk in time to also avoid a ...
Biodexa Receives Orphan Drug Designation in Europe for eRapa in FAP New designation follows the U.S. Food and Drug Administration (FDA) Orphan Drug Designation for eRapa in FAP granted ...
New designation follows the U.S. Food and Drug Administration (FDA) Orphan Drug Designation for eRapa in FAP granted in 2019 ...
The new test, known as the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, detects amyloid plaques through blood testing, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results